About the Conference: Cavendish Global, in partnership with co-hosts – The University of California San Diego, The J. Craig Venter Institute, The Scripps Research Institute, The Sanford-Burnham Medical Research Institute, The Sanford Consortium for Regenerative Medicine, and The Institute of the Americas – will provide a peer-to-peer platform for leading family offices, foundations and sovereign wealth funds from around the world to share their passion for sustainable philanthropy and impact investing in areas of national and global importance.
About the Conference: The purpose of the event, created by local venture investor and former stock broker Sheryl Marshall in partnership with Babson College, is to highlight several women-led startups, give them a chance to introduce their businesses to investors, and increase awareness of the current venture-funding gap that exists for women-led businesses. Join us on April 7, 2015 at District Hall, 75 Northern Avenue, Boston, MA for this event: “Connecting Women to Capital” – a Day of Women Pitching, Speakers, Workshops and Fun!
The 24th Annual Dynamic Women in Business Conference is being held at Harvard Business School on Saturday, February 21, 2015. This year, the conference will focus on how to “go beyond” the status quo – be it taking that leap in your entrepreneurial venture, solving increasingly global business challenges, or mentoring employees within your organization. What actions can you take to make a lasting impact in today’s dynamic business world?
Conference Title: Organic Culture Models for Toxicology – In Vitro Tools for Modeling and Predicting Organ-Specific Toxicity
About the Conference: TiECon Canada is TiE's flagship conference for entrepreneurs, SMEs, industry veterans, investors, and other members of the Canadian business community. Organized in partnership with Canadian sister chapters in Toronto and Vancouver, and global TiE (The Indus Entrepreneurs) chapters in Silicon Valley and Boston, this event features industry leaders, technology gurus and investors from different sectors and all spheres of business.
Empiriko’s CSO Mukund Chorghade, Ph.D. presents at American Chemical Society National Meeting & Exposition, San Francisco, CA, August 10-14, 2014
Biomimiks™ as Chemosynthetic Livers: predict, prepare and prove the structure, activity and toxicity of drug metabolites
Featuring Keynote Speaker:
CEO and Founder, Empiriko
Co-founder, AgroGreen Biofuels
From MIT Blackjack Team, To Serial Entrepreneur:
How Lessons Learned in Las Vegas can be Applied to Business
By Maximilian Klietmann, VP of Marketing, LSN
RESI ended on Monday evening with over 400 attendees and over 660 partnering meetings. Additionally, 33 of the 150 biotech and medtech companies attending RESI were selected for the RESI Innovation Challenge, and competed for “RESI Cash” invested by conference attendees. Well, the winners are in!
Empiriko’s CEO and Founder, Pam Randhawa, participates in panel on May 5, 2014, Burlington Marriott, Burlington MA.
Moderator: Roger Frechette, Ph.D., Co-Founder and Partner, New England PharmAssociates, LLC
Empiriko, a green chemistry company, is showcasing its unique, holistic approach to drug discovery, development and patient outcomes by analyzing the many interactions that may occur among diseases, drugs and patients. We iteratively test and refine our in silico models -- generating hypotheses that are tested in experimental laboratories -- to simulate and predict optimal drug designs, better diagnostics and improved patient outcomes